The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16 600 patients in primary care

  • P. Bramlage, D. Pittrow, W. Kirch
  • Current Medical Research and Opinion, September 2004, Informa Healthcare
  • DOI: 10.1185/030079904x3861

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage